Differential growth factor control of bone formation through osteoprogenitor differentiation

Bone

Volumn 34, Issue 3, 2004, Pages 402-411

  Chaudhary, L R ^a   Hofmeister, A M ^b   Hruska, K A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

BMP 7; Differentiation; FTIR; Mineralization; Osteoprogenitor

Indexed keywords

ALIZARIN RED S; ALKALINE PHOSPHATASE; ASCORBIC ACID; CALCIUM; CALCIUM PHOSPHATE; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR 2; GLYCEROL 2 PHOSPHATE; GROWTH FACTOR; HYDROXYAPATITE; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; SIALOPROTEIN;

ARTICLE; BIOMINERALIZATION; BONE MARROW; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; CRYSTAL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MORPHOLOGY; OSSIFICATION; OSTEOBLAST;

BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; GROWTH SUBSTANCES; HUMANS; OSTEOGENESIS; PLATELET-DERIVED GROWTH FACTOR; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 1542376119     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2003.11.014     Document Type: Article

References (51)

1. + cells. J. Cell. Biochem. 81:2001;23-38.
2. Bonewald L.F., Harris S.E., Dallas M.R., Dallas S.L., Camacho N.P., Boyan B.et al. Von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Calcif. Tissue Int. 72:2003;537-547.
3. Boudreaux J.M., Towler D.A. Synergistic induction of osteocalcin gene expression: identification of a bipartite element conferring fibroblast growth factor 2 and cyclic AMP responsiveness in the rat osteocalcin promoter. J. Biol. Chem. 271:1996;7508-7515.
4. Chaudhary L.R., Avioli L.V. Regulation of interleukin-8 gene expression by interleukin-1β, osteotropic hormones, and protein kinase inhibitors in normal human bone marrow stromal cells. J. Biol. Chem. 271:1996;16591-16596.
5. Chaudhary L.R., Avioli L.V. Activation of extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2) by FGF-2 and PDGF-BB in normal human osteoblastic and bone marrow stromal cells: differences in mobility and in-gel renaturation of ERK1 in human, rat and mouse osteoblastic cells. Biochem. Biophys. Res. Commun. 238:1997;134-139.
6. Chaudhary L.R., Avioli L.V. Identification and activation of mitogen-activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells: attenuation of MAP kinase activation by cAMP, parathyroid hormone and forskolin. Mol. Cell. Biochem. 178:1998;59-68.
7. Chaudhary L.R., Avioli L.V. Extracellular-signal regulated kinase signaling pathway mediates downregulation of Type 1 procollagen gene expression by FGF-2, PDGF-BB, and okadaic acid in osteoblastic cells. J. Cell. Biochem. 76:2000;354-359.
8. Cheifetz S., Li I.W., McCulloch C.A., Sampath K., Sodek J. Influence of osteogenic protein-1 (OP-1;BMP-7) and transforming growth factor-beta 1 on bone formation in vitro. Connect. Tissue Res. 35:1996;71-78.
9. Cheng S., Yang J.W., Rifas L., Zhang S., Avioli L.V. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology. 134:1994;277-286.
10. Coffin J.D., Florkiewicz R.Z., Neumann J., Mort-Hopkinas T., Dorn G.W.L.P. II, Howles P.N.et al. Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol. Biol. Cell. 6:1995;1861-1873.
11. Debiais F., Hott M., Graulet A.M., Marie P.J. The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J. Bone Miner. Res. 13:1998;645-654.
12. DeLuca F., Baron J. Control of bone growth by fibroblast growth factors. Trends Endocrinol. Metab. 10:1999;61-65.
13. Deng C., Wynshaw-Boris A., Zhou F., Kuo A., Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 84:1996;911-921.
14. Frank O., Heim M., Jakob M., Barbero A., Shafer D., Bendik I.et al. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J. Cell. Biochem. 85:2002;737-746.
15. Gadaleta S.J., Camacho N.P., Mendelsohn R., Boskey A.L. Fourier transform infrared microscopy of calcified turkey leg tendon. Calcif. Tissue Int. 58:1996;17-23.
16. Hofmeister A.M. Infrared reflectance spectra of fayalite, and absorption data from assorted olivones, including pressure and isotopes effects. Phys. Chem. Miner. 24:1997;535-546.
17. Hughes F.J., Collyer J., Stanfield M., Goodman S.A. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology. 136:1995;2671-2677.
18. Hunter G.K., Goldberg H.A. Nucleation of hydroxyapatite by bone sialoprotein. Biochemistry. 90:1993;8562-8565.
19. Hurley M.M., Abreu C., Harrison J.R., Lichtler A.C., Raisz L.G., Kream B.E. Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268:1993;5588-5593.
20. Kang Y.-M., Yeh Y.-L., Graves D.T. Interleukin-1 modulates phosphorylation of proteins in human osteoblastic cells. J. Bone Miner. Res. 10:1995;96-105.
21. Kim H.D., Valentini R.F. Human osteoblast response in vitro to platelet-derived growth factor and transforming growth factor-delivered from controlled-release polymer rods. Biomaterials. 18:1997;1175-1184.
22. Lecanda F., Avioli L.V., Cheng S.L. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J. Cell. Biochem. 67:1997;386-398.
23. Li I.W.S., Cheifetz S., McCulloch C.A.G., Sampath K.T., Sodek J. Effects of osteogenic protein-1 (OP-1, BMP-7) on bone matrix protein expression by fetal rat calvarial cells are differentiation stage specific. J. Cell. Physiol. 169:1996;115-125.
24. Lian J.B., Stein G.S., Canalis E., Robey P., Boskey A.L. Bone formation: osteoblast lineage cells, growth factors, matrix proteins, and the mineralization process. Fabus M.J. Primer on the metabolic bone diseases and disorders of mineral metabolism. 1999;14-29 Lippincott Williams and Wilkins, Philadelphia.
25. Lisignoli G., Zini N., Remiddi G., Piacentini A., Puggioli A., Trimarchi C.et al. Basic fibroblast growth factor enhances in vitro mineralization of rat bone marrow stromal cells grown on non-woven hyaluronic acid based polymer scaffold. Biomaterials. 22:2001;2095-2104.
26. Mansukhani A., Bellosta P., Sahni M., Basilico C. Signaling by fibroblast growth factor (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J. Cell Biol. 149:2000;1297-1308.
27. Mayahara H., Ito T., Nagai H., Miyajima H., Tsukuda R., Taketomi S.et al. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors. 9:1993;73-80.
28. Mitlak B.H., Finkelman R.D., Hill E.L., Li J., Martin B., Smith T.et al. The effects of systemically administered PDGF-BB on the rodent skeleton. J. Bone Miner. Res. 11:1996;238-247.
29. Moltz K.C., Friedman A.H., Nehgme R.A., Kleinman C.S., Carpenter T.O. Ectopic cardiac calcification associated with hyperparathyroidism in a boy with hypophosphatemic rickets. Curr. Opin. Pediatr. 13:2001;373-375.
30. Mundy G.R. Bone remodeling. Fabus M.J. Primer on the metabolic bone diseases and disorders of mineral metabolism. 1999;30-38 Lippincott Williams and Wilkins, Philadelphia.
31. Nakamura T., Hanada K., Tamura M., Shibanushi T., Nigi H., Tagawa M.et al. Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology. 136:1995;1276-1284.
32. Nochi H., Sung J.H., Lou J., Adkisson H.D., Hruska K.A., Maloney W.J. Adenovirus mediated BMP-13 gene transfer induces chondrogenic differentiation of murine mesenchymal progenitor cells. J. Bone Miner. Res. 2004;. (in press).
33. Okazaki R., Ikeda K., Sakamoto A., Nakano T., Morimoto K., Kikuchi T.et al. Transcriptional activation of c-fos and c-Jun proto-oncogenes by serum growth factors in osteoblast-like MC3T3-E1 cells. J. Bone Miner. Res. 7:1992;1149-1155.
34. Ornitz D.M., Xu J., Colvin J.S., McEwen D.G., MacArthur C.A., Coulier F.et al. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271:1996;15292-15297.
35. Paschalis E.P., Betts F., DiCarlo E., Mendelsohn R., Boskey A.L. FTIR microspectroscopic analysis of normal human cortical and trabecular bone. Calcif. Tissue Int. 61:1997;480-486.
36. Pearson G., Robinson F., Gibson T.B., Xu B.-E., Karandikar M., Berman K.et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22:2001;153-183.
37. Reddi A.H. Bone morphogenesis and modeling: soluble signals sculpt osteosomes in the solid state. Cell. 89:1997;159-161.
38. Rice D.P., Aberg T., Chan Y., Tang Z., Kettunen P.J., Pakarinen L.et al. Integration of FGF and TWIST in calvarial bone and suture development. Development. 127:2000;1845-1855.
39. Robinson D., Bab I., Nevo Z. Osteogenic growth peptide regulates proliferation and osteogenic maturation of human and rabbit bone marrow stromal cells. J. Bone Miner. Res. 10:1995;690-696.
40. Rodan S.B., Wesolowski G., Thomas K.A., Yoon K., Rodan G.A. Effects of acidic and basic fibroblast growth factors on osteoblastic cells. Connect. Tissue Res. 20:1989;283-288.
41. Sampath T.K., Maliakal J.C., Hauschka P.V., Jones W.K., Sasak H., Tucker R.F.et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 267:1992;20352-20362.
42. Stanford C.M., Jacobson P.A., Eanes E.D., Lembke L.A., Midura R.J. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J. Biol. Chem. 270:1995;9420-9428.
43. Suzuki A., Shinoda J., Kanda S., Oiso Y., Kozawa O. Basic fibroblast growth factor stimulates phosphatidylcholine-hydrolyzing phospholipase D in osteoblast-like cells. J. Cell. Biochem. 63:1996;491-499.
44. Walsh S., Jefferiss C., Stewart K., Jordan G.R., Screen J., Beresford J.N. Expression of the developmental markers STRO-1 and alkaline pohoisphatase in cultures of human marrow stromal cells: regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1-4. Bone. 27:2000;185-195.
45. Wennberg C., Hessle L., Lundberg P., Mauro S., Narisawa S., Lerner U.H. et al. Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J. Bone Miner. Res. 15:2000;1879-1888.
46. 3-integrin expression. J. Bone Miner. Res. 15:2000;1731-1745.
47. Xiao G., Gopalakrishnan R., Jiang D., Reith E., Benson M.D., Franceschi R.T. Bone morphogenetic proteins, extracellular matrix, and mitogen activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J. Bone Miner. Res. 17:2002;101-110.
48. Yamaguchi A., Ishizuya T., Kintou N., Wada Y., Katagiri T., Wozney J.M. et al. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem. Biophys. Res. Commun. 220:1996;366-371.
49. Yu X., Hsieh S.-Cl.B.W., Graves D.T. Temporal expression of PDGF receptors and PDGF regulatory effects on osteoblastic cells in mineralizing cultures. Am. J. Physiol. 272:1997;C1709-C1716.
50. Zhang L., Leeman E., Carnes D.C., Graves D.T. Human osteoblasts synthesize and respond to platelet-derived growth factor. Am. J. Physiol. 261:1991;C348-C354.
51. Zhou H.Y., Takita H., Fujisawa R., Mizuno M., Kuboki Y. Stimulation by bone sialoprotein of calcification in osteoblast-like MC3T3-E1 cells. Calcif. Tissue Int. 56:1995;403-407.